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ABSTRACT: Phospholipase A/acyltransferase 3 (PLAAT3) and PLAAT4 are
enzymes involved in the synthesis of bioactive lipids. Despite sequential and
structural similarities, the two enzymes differ in activity and specificity. The relation
between the activity and dynamics of the N-terminal domains of PLAAT3 and
PLAAT4 was studied. PLAAT3 has a much higher melting temperature and exhibits
less nanosecond and millisecond dynamics in the active site, in particular in loop
L2(B6), as shown by NMR spectroscopy and molecular dynamics calculations.
Swapping the L2(B6) loops between the two PLAAT enzymes results in strongly
increased phospholipase activity in PLAAT3 but no reduction in PLAAT4 activity,
indicating that this loop contributes to the low activity of PLAAT3. The results show
that, despite structural similarity, protein dynamics differ substantially between the
PLAAT variants, which can help to explain the activity and specificity differences.
■ INTRODUCTION
Phospholipase A/acyltransferases (PLAATs) are a five-
membered family of enzymes. They were first identified as
H-Ras-like class II tumor suppressors (HRASLS).1 Numerous
studies in different scientific domains led to a variety of names
(Table S1). The five members are part of a larger, diverse
superfamily of NlpC/P60 thiol proteases or papain-like
proteases because of their sequence similarity with lecithin:
retinol acyltransferases (LRAT), a member of the NlpC/P60
family.2 PLAATs share a highly conserved sequence NCEHFV,
which contains the catalytic cysteine that acts as the
nucleophile.2−5 The cysteine is part of a catalytic triad that
also contains two histidine residues, one acting as the base that
deprotonates the sulfhydryl group of the nucleophile and the
other stabilizing the imidazole ring of the basic histidine in
PLAAT2−5. In PLAAT1, the second histidine is replaced by
asparagine. This CHH catalytic triad is a hallmark signature of
the NlpC/P60 superfamily of proteins.2,6−8 Four of the
PLAAT enzymes are membrane anchored proteins having a
C-terminal trans-membrane domain, while PLAAT5, the
largest of all PLAATs, lacks this anchor.9 The structures of
PLAAT2, PLAAT3, and PLAAT4 have been reported (Figure
1).2,7,8 Depending on the structure, the secondary structure
comprises three or four α-helices and an antiparallel β-sheet
containing five or six strands, similar to classic segregated α+β-
folds of papain-like proteases.2,6 The PLAATs catalyze the
formation of N-acyl phosphatidyl ethanolamines (NAPE),
which undergo further conversions to form N-acylethanol-
amines (NAEs), an important class of bioactive lipids that
plays a variety of roles in processes such as anti-inflammation
(N-palmitoyethanolamine)10−12 and catabolism of fat (N-
oleoylethanolamine),13 and they have antiapoptotic activity
(N-stearoylethanolamine)13 and act as ligands for cannabinoid
receptors (N-arachidonoylethanolamine, anandamide).14−16
PLAATs, as the name indicates, demonstrate phospholipase
A1/2 (PLA1/2) activities with both phosphatidylcholine (PC)
and phosphatidylethanolamine (PE) acting as sub-
strates.3,9,17−20 All PLAATs except PLAAT3 show specificity
for the sn-1 position, whereas it has been suggested that
PLAAT3 may prefer either the sn-1 or the sn-2 position,
depending on the type of substrate and assay conditions.21−23
The second part of the name comes from the ability to transfer
the acyl-chain of a phosphoglyceride, for example PC, to the
amino group of PE, leading to the formation of NAPEs.
Furthermore, PLAATs can act as O-acyltransferases, trans-
ferring an acyl-chain to the sn-1 or sn-2 position of a
lysophospholipid, for example lysophosphatidylcho-
line.2,3,17,19,24 PLAAT3 is found mostly in white adipose tissue
and less in brown adipose tissue.21,25 In white adipose tissue, it
modulates lipolysis and therefore is a critical factor in obesity,
as was elegantly demonstrated in mice models by Jaworski et
al.25 PLAAT3 was discovered as being a tumor suppres-
sor;20,26−32 however, other reports showed that PLAAT3
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increases tumor progression.29,33 PLAAT3 shows a preference
for PLA activity over N-acyltransferase activity.17,24 PLAAT4 is
found in keratinocytes, where it activates transglutaminase I
(TG1), which in turn produces a cornified envelope, necessary
for cell proliferation and survival, and skin to function as a
physical and water barrier.34−37 PLAAT4 was shown to work
as a class II tumor suppressor and is downregulated in psoriasis
and skin cancer.38−44 PLAAT4 is a homologue of PLAAT3,
showing 58% sequential identity and 72% similarity,38,39 and it
also shows more PLA1/2 activity than N-acyltransferase
activity.17,19,24 However, the two enzymes exhibit a contrasting
characteristic regarding the PLA1/2 activity. The transmem-
brane C-terminal domain (CTD) is crucial for PLAAT3
PLA1/2 activity, and truncation of this domain has been shown
to result in loss of phospholipase activity by Uyama et al.45 In
contrast, Golczak et al.2 demonstrated that, unlike truncated
PLAAT3, truncated PLAAT4 is capable of phospholipase
activity, suggesting that the transmembrane C-terminal domain
is not critical for PLAAT4 PLA1/2 activity. Furthermore, these
authors demonstrated that the truncated PLAAT4 is the more
active phospholipase. Clearly, despite the structural similarities,
the activity depends both on the exact sequence and the
truncation. We wondered whether differences in protein
dynamics could explain the differences in activity. In the
current study, the dynamics of the soluble N-terminal domains
(NTDs) of PLAAT3 and PLAAT4 were probed using NMR
spectroscopy on the nanosecond and millisecond time scales.
The results show that generally PLAAT4 is more flexible on
the nanosecond time scale and exhibits more millisecond
dynamics around the active site than PLAAT3. MD
calculations support these findings and suggest that one
particular active site loop could influence activity. A loop-
swapping mutagenesis experiment shows that PLAAT3 gains
activity with the loop taken from PLAAT4. The reasons for the
differences in dynamics and the relevance of these findings for
the full-length proteins are discussed.
■ MATERIALS AND METHODS
Construction of DNA Fragments. DNA sequences
encoding the human N-terminal soluble form (residues 1−
125) of PLAAT3 or PLAAT4 (Uniprot ID P53816 and
Q9UL19, respectively) with N-terminal His6 tag and a TEV
cleavage site were ordered from GeneArt. The fragments were
inserted in-frame into the bacterial expression vector pET-28a
using the NcoI and XhoI restriction sites. Fragment-based
mutagenesis46 was carried out by forward and reverse primers
designed to swap the L2(B6) loop of PLAAT3 (103E-V-L-Y-
K-L-T-S-E111) with that of PLAAT4 (103K-M-K-Y-S-I-V-S-
R111) and vice versa.
Protein Production and Purification. Chemically
competent Escherichia coli BL21-DE3pLys cells were trans-
formed with the plasmids for protein production. The bacteria
were cultured overnight in 50 mL of LB medium with 50 μg/
mL kanamycin at 37 °C under shaking. For 15N-labeling, 5 mL
of the overnight preculture was transferred to 500 mL minimal
medium with 50 μg/mL kanamycin. When the OD600 reached
0.6, the temperature was lowered to 22 °C, and gene
expression was induced by addition of 0.5 mM IPTG. The
culture was incubated for 5 h before cells were harvested by
centrifugation at 6000 rpm at 4 °C. The pellet was
Figure 1. Crystal (A and B) and NMR (C and D) structures of PLAAT2, PLAAT3, and PLAAT4. The PDB entry codes are indicated in
brackets.2,7,8 Dashed lines in A and B are indicated for visual continuity of the loops.
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resuspended in 5 mL of 50 mM Tris−HCl buffer (pH 7.5)
followed by freezing at −80 °C overnight. The cells were
thawed the next day in the presence of DNase I and lysozyme
and lysed using a French press. The lysate was centrifuged at 4
°C at 25 000g for 45 min. The supernatant of the cell lysate
containing the His6-tagged soluble protein was then loaded on
a HiTrap-Nickel column equilibrated with 50 mM Tris pH 7.5,
500 mM NaCl, and 5 mM imidazole. The protein was eluted
using a linear imidazole concentration gradient from 0 to 0.5
M. The collected fractions were pooled and dialyzed overnight
using a 3.5 kDa molecular weight cutoff cellulose membrane at
4 °C in 50 mM Tris, pH 7.5, 500 mM NaCl, 0.5 mM EDTA
buffer to remove imidazole. His6-tagged TEV protease was
added for the cleavage of the His6-tag on PLAAT during
dialysis overnight. The mixture was loaded again on a His6-
Trap Nickel column to collect the N-terminal PLAAT3 and
PLAAT4 domains. The buffer was changed into 50 mM Tris-
HCl, 50 mM NaCl, 10 mM DTT, pH 7.5. The volume of the
sample was reduced to 2.5 mL using a 5 kDa MWCO Amicon
Ultracentrifugal filter (EMD Millipore) at 2200g and 15 °C.
The concentrated sample was loaded on and eluted from a
Superose12 gel filtration column in 30 mM sodium phosphate
buffer with 30 mM NaCl and 10 mM DTT at pH 7.0. All
NMR samples contained 1.5 mM uniformly 15N -labeled
protein in this buffer with 7% D2O added for lock.
Thermofluor-Based Melting Temperature (Tm) Anal-
ysis. Thermofluor analysis was performed on a CFX96 Real-
Time PCR system (Bio-Rad) to determine the thermal
stability of PLAAT proteins. Duplicate protein samples of 25
μL were prepared in 30 mM sodium phosphate buffer (pH
7.0), 25 mM sodium chloride, and 10 mM DTT in 96-well
Concord Polycarbonate PCR plates (Bio-Rad) using SYPRO
Orange (Sigma-Aldrich) as a fluorescent probe. After sealing
with Optical-Quality Sealing Tape (Bio-Rad), plates were
vortexed and centrifuged for 30 s using an MPS 1000 mini
PCR Plate Spinner (Labnet). Melting curves were obtained by
detection of fluorescence using the FRET channel of the RT-
PCR machine. The temperature was increased in steps of 0.5
°C increments. At each point, the sample was incubated for 30
s before measuring the fluorescence. At the end, the reaction
was stopped by heating at 90 °C for 5 min. The results were
analyzed in CFX Manager 3.1 (Bio-Rad). The temperature
corresponding to the maximum of the first derivative of the
melting curve was taken to be the melting temperature (Tm).
Phospholipase Assay. Protein solutions (200 μL, 0.1 mg/
mL) were diluted with equal volumes of buffer A (50 mM Tris-
HCl, pH 8, 50 mM NaCl, 2 mM DTT). These solutions were
added to white 96-well plates (60 μL per well, in triplicate). A
standard dilution series of the product BODIPY FL-Cs
(ThermoFischer Scientific) was prepared in pure DMSO in
the following concentrations: 0.0 μM (pure DMSO), 0.005,
0.01, 0.05, 0.1, 0.5, and 1 μM. The product was diluted with a
1:1 mixture of buffer A and buffer B (50 mM Tris-HCl pH 8,
100 mM NaCl, 1 mM CaCl2). The solutions of standards were
added in the 96-well plate (100 μL each). The liposome
mixture was prepared by mixing DOPC (5.1 μL, 10 mM stock
in ethanol), DOPG (5.1 μL, 10 mM stock in ethanol), and the
substrate Red/Green BODIPY PC-A2 dissolved in pure
DMSO (5.1 μL, 1.5 mM, ThermoFischer Scientific). The
mixture was injected slowly (in about 45 s) under vortexing
into a glass vial containing 1.5 mL of assay buffer using a pipet
fitted with a narrow orifice gel-loading tip. The liposome
mixture (50 μL) was added to each well of the 96-well plate in
which the enzymes were to be tested. Then, PLAAT protein
solutions (50 μL) were transferred from the white 96-well
plate to the black microplate wells containing the liposome
mixture at 37 °C. The fluorescence measurement was started
immediately, every 20 s in 60 min on a Tecan GENios with a
gain of about 54 and an excitation filter at 488 nm and
emission filter at 530/590 nm.
T1, T2, and NOE Measurements. NMR experiments were
carried out at 25 °C on 600 and 850 MHz Bruker Avance III
spectrometers equipped with TCI cryoprobes. Standard Bruker
pulse sequences were used for T1 (hsqct1etf3gpsitc3d), T2
(hsqct2etf3gpsitc3d), and NOE (hsqcnoef3gpsi) experiments.
15N−1H NOE spectra with and without amide proton
saturation were recorded in an interleaved fashion recording
80 transients per point, yielding very high signal-to-noise data.
The final HSQC spectra contained 2048 and 200 points in the
1H and 15N dimensions, respectively. In the T1 and T2
experiments, water saturation was avoided using low power
water-flip-back pulses. The mixing times (s) used for the
determination of T1 were 0.01 (2×), 0.16, 0.22, 0.35 (2×),
0.48, 0.6, 0.8 (2×), 1.0, and 1.2 with duplicates for error
estimation. Mixing times (s) for T2 determination were 0,
0.034 (2×), 0.05, 0.07 (2×), 0.085, 0.10, 0.135 (2×), 0.17, 0.2
(2×), and 0.24. A recycle delay of 4 s was used for all T1, T2,
and NOE experiments. All spectra were processed with Bruker
TOPSPIN with linear prediction applied to the 15N dimension
and qsine and Gaussian window functions. NOE values were
calculated as the ratio of peak intensities in the experiment
with and without proton saturation. To obtain T1 and T2
values, the experimental data points (peak heights) were fitted
to a curve I0 × exp(−t/Ti), where I0 is the peak intensity of the
reference spectra, and fit parameter errors were estimated using
Monte Carlo simulations. All NOE, T1, and T2 analyses were
performed using the Bruker Protein Dynamics software suite.
1H−15N HSQC spectra of PLAAT3 and PLAAT4 were
assigned using BMRB entries 16883 and 18012, respec-
tively.47,48
Relaxation Dispersion Measurements. Constant relax-
ation time CPMG experiments were performed for the
backbone 15N nuclei of PLAAT3 and PLAAT4 using a
modified ST-CW CPMG pulse sequence.49 A series of two-
dimensional (2D) spectra with 1024/60 complex points
(1H/15N) were recorded with a relaxation delay (Trelax) of 40
ms and cpmg frequencies (Hz) set to 100, 200 (2×), 300, 400
(2×), 500, 600, 700, 800 (2×), 900, and 1000, run in an
interleaved fashion, followed by a reference spectrum with
Trelax = 0. Duplicates (2×) were used to estimate the error in
the effective transverse relaxation rate (R2,eff). Peaks were fitted
with FuDa (Hansen, http://www.biochem.ucl.ac.uk/hansen/
fuda/) to obtain intensities, and R2,eff values were calculated
from the peak intensities using the formula: R2,eff(νCPMG) =
−1/Trelax·ln(I (νCPMG)/I0), where I0 is the peak intensity in the
reference spectrum. The R2,eff values were corrected for R1
contribution using the formula described by Jiang et al.49 with
0.95 and 10.5 s−1 as an estimate for R1 and R2 contribution for
all residues. The resulting relaxation dispersion profiles of
residues that show dispersion obtained at two fields were fitted
to Carver-Richards equation and modeled to a two-state model
by using CATIA (Hansen, http://www.biochem.ucl.ac.uk/
hansen/catia/), and the exchange rate constant (kex) and the
fraction of the minor state (pB) were obtained as the global
output of CATIA, whereas the absolute chemical shift
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differences between minor and major states (|Δω|) were
obtained for individual residues.
Model-Free Analysis. Automated model-free analysis was
performed using Bruker Protein Dynamics software suite. The
NH bond length was set to 1.02 Å, and the NH chemical shift
anisotropy was set to −172 ppm. To ensure good model
fitting, calculated errors in T1, T2, and NOE were overridden
with an error of 2%, as the calculated errors were smaller due
to very high signal-to-noise. The software performs the
following actions: Using the two-field T1, T2, and NOE data
sets, the global correlation time (τc) and reduced spectral
densities j(0), j(ωN), j(0.87ωH) were calculated. The reduced
spectral densities were then used to estimate the order
parameters (S2), the ratio D||/D_ of the diffusion tensor, and
relaxation exchange (Rex) parameters for each residue.
Estimation of τc required exclusion of dynamic residues,
which was done by excluding all residues with NOE values less
than 0.65 residues, with T2 smaller than the difference between
mean and one standard deviation and with large T2 values as
compared to T1 because these residues might undergo
conformational exchange. The T1, T2, and NOE values of
each residue were fitted to two models, assuming isotropic
modeling: M1(S2) and M2(S2, τe).
50−55
Theoretical Calculation of τc. Theoretical hydrodynamic
calculation to determine the τc was done using the program
HYDRONMR.56 The structures from PDB entries 2KYT and
2MY9 were used as input for atomic coordinates. The effective
radius of atomic elements was set to 3.1 Å, the temperature to
25 °C, and solvent viscosity to 9.1 mP to match our
experimental conditions. N−H bonds with explicit hydrogens
were chosen as the source of the dipole vectors to calculate the
NMR parameters and dipolar couplings. The gyromagnetic
ratio of N was set to −2.7126 × 107 rad s−1T−1, the N−H
distance was set to 1.02 Å, and the CSA was set to −172 ppm.
τc was calculated for two magnetic fields, 14 and 20 T to match
our experimental data.
MD Simulations. MD simulations were performed using
Gromacs-5.1.57,58 The NMR structures of PLAAT3 (2KYT)8
and PLAAT4 (2MY9)7 were selected for the simulations as
starting structures and topology files were created. The
AMBER ff99sb-ILDN force-field provided with GROMACS
was used.59 The models were then solvated in a periodic water
box of 10 and 20 Å cubic edge length for PLAAT3 and
PLAAT4, respectively. The latter is larger due to the elongated
conformation of the protein. The TIP3P water model was
used.60,61 Three Na+ counterions were automatically placed by
the GROMACS program throughout the water box such that
the final system had net zero charge. The systems were energy
minimized by 5000 steps of minimization using the steepest
descent algorithm and further equilibrated under NVT and
NPT conditions for 500 ps with a step size of 2 fs, using
position restraints on the protein and a temperature of 27 °C
and 1 atm pressure controlled by the velocity rescaling
(modified Berendsen) thermostat62 and Parrinello−Rahman
barostat.63 The equilibrated systems were subjected to a 100 ns
simulation run under NPT without any position restraints, and
coordinates were saved after every picosecond. Two
simulations were carried out with different starting seeds for
both PLAAT3 and PLAAT4, where each seed represents a
simulation at a different velocity. The trajectories were
Figure 2. 15N relaxation data for PLAAT3 (solid circles) and PLAAT4 (open circles) at 14 and 20 T. The 15N-NOE, 15N-T1, and
15N-T2 as well as
T1/T2 are plotted against the residue number. Errors were estimated by the Monte Carlo method using 95% confidence level as incorporated in the
Bruker Protein Dynamics software suite.
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analyzed using the in-built modules available in the
GROMACS suite and visualized by means of the VMD64/
Chimera program.65
Principal component analysis was carried out by first
building the covariance matrix of atomic fluctuations and
then generating a set of eigenvectors and eigenvalues by the
diagonalization of the covariance matrix. The two eigenvectors
that corresponded to the two largest eigenvalues were chosen
as the principal components describing most of the collective
motions or essential dynamics. The residues involved in these
two largest eigenvectors were extracted by using a cutoff of 2 Å
RMS fluctuations of individual atoms described by the two
eigenvectors using an in-house program. The motions of these
residues were further analyzed by observing the MD trajectory.
In Silico Mutagenesis. L2(B6) loops were swapped
between PLAAT3 and PLAAT4 by mutating the wild-type
NMR structures with Chimera65 and selecting the most
favorable conformation for each mutated residue. Clashes were
removed during energy minimization in Gromacs.57
Salt-Bridge Analysis. Two MD simulations of 100 ns of
L2(B6) mutant PLAATs were run using the same protocol as
described above. Salt bridge populations were calculated for
both wild-type and mutant proteins using VMD64 by sampling
a structure every 10 ps. The data were extracted and analyzed
using an in-house written python program. Only residue pairs
with salt bridges having populations of 20% or more, averaged
over both runs, were taken into consideration.
■ RESULTS
PLAAT4 is Inherently More Flexible than PLAAT3. In
the remaining, PLAAT3 and PLAAT4 refer to the truncated,
NTD versions of the proteins. To characterize the differences
in dynamics between PLAAT3 and PLAAT4, the melting
temperature (Tm) and the mobility on various time scales were
determined. The Tm values were found to be 78.0 (±0.5) °C
for PLAAT3 and 62.5 (±0.5) °C for PLAAT4. The large
difference of 15 °C suggests that PLAAT3 has a more rigid
structure with strong inter-residue, noncovalent interactions.
1H−15N HSQC spectra of PLAAT3 and PLAAT4 were
obtained and assigned based on the published data (Figure
S1).47,48 Fewer resonances are observed in the spectrum of
PLAAT4 than in that of PLAAT3, which suggests that more
Figure 3. Representation of salt bridge networks (yellow dashes) in PLAAT3 (PDB ID: 2KYT) (A)8 and PLAAT4 (PDB ID: 2MY9) (B).7 Salt
bridges were defined as a pair of basic and acidic residues with a nitrogen and an oxygen atom of the basic and acidic side chains, respectively,
within 3.2 Å in at least one of the 20 NMR structures. Green spheres represent the Cα atoms of the bridged residues. (C) Modified nomenclature
of PLAAT3 (red, PDB ID: 2KYT) and PLAAT-4 (blue, PDB ID: 2MY9) according to Table S2 is included for reference.
Table 1. 20% trimmed average and standard deviation in brackets of 15N T1, T2, and NOE values of PLAAT3 and PLAAT4
obtained at 14 and 20 T experiments. The rotational correlation time τc for PLAAT3 (4) was calculated using subsets of 40
(33) or 57 (37) amides at 14 and 20 T, respectively
14 T 20 T
T1 (ms) T2 (ms) NOE T1 (ms) T2 (ms) NOE
PLAAT3
20% trimmed mean 720(2) 90(1) 0.66(0.01) 1060(5) 80(2) 0.78(0.02)
τc (ns) 8.5(0.2) 8.2(0.4)
PLAAT4
20% trimmed mean 900(4) 50(8) 0.71(0.01) 1380(10) 40(1) 0.83(0.01)
τc (ns) 12.6(0.3) 12.5(0.4)
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amides are mobile on the millisecond time scale or their
protons are in rapid exchange with the solvent, causing line
broadening due to chemical exchange. To determine the
motions of PLAAT3 and PLAAT4 at pico-/nanosecond time
scale, the 15N backbone amide T1, T2, and heteronuclear NOE
parameters were determined at 14 T (600 MHz 1H frequency)
and 20 T (850 MHz 1H frequency). The data are presented in
Figure 2 and Tables S3−S6.
Relaxation parameters could be determined for 98 residues
of PLAAT3 and 71 residues of PLAAT4. The low NOE values
of the loop L1 in both proteins indicate that this loop is highly
disordered, which is in line with previous findings.2,7,8 Note
that we have introduced minor modifications to the naming
conventions of the secondary structural elements of PLAAT3
and PLAAT4 published in refs 7 and 8 (Table S2, Figure 3C).
We have included the nomenclature for two main loops L1
(residues 38−57) and L2 (residue 100−109/110) and the β
strand B6 (residues 103−104) as a part of the loop L2 and
thus renamed as L2(B6). Due to the flexibility of the N-
terminus and loop L1, the NOE and T2 values of those regions
differ much from the rigid parts of the proteins and should not
be considered for the calculation of average T1, T2, and NOE
values. The 20% trimmed average NOE and T1 values for
PLAAT4 were higher than for PLAAT3, and the one for T2
was lower (Table 1).
Thus, the T1/T2 ratio is much larger for PLAAT4 than for
PLAAT3, resulting in rotational correlation times (τc) of 8.4
and 12.5 ns for PLAAT3 and PLAAT4, respectively. This is
remarkable, because the proteins have similar molecular
weights, of 14.4 kDa and 14.7 kDa, respectively. Theoretical
estimations of average τc from all models in the NMR
ensemble structures (2kyt.pdb8 for PLAAT3 and 2my9.pdb7
for PLAAT4) using HYDRONMR56 yield 9 ± 1 and 11 ± 1
ns, respectively, values close to experimentally determined
ones. PLAAT3 is more globular with a compact structure,
perhaps due to a distributed network of 17 salt bridges,
whereas PLAAT4 is a more elongated molecule with only 10
salt bridges, concentrated in certain parts of the protein, as
illustrated in Figure 3. It can also not be excluded that
PLAAT4 has a tendency for transient self-interactions under
the high concentration (1.5 mM) used in the NMR samples,
leading to a higher τc. Residues with NOE values below two
standard deviations of the trimmed average were identified as
residues showing internal motions and residues with T1/T2
ratios two standard deviations above or below the trimmed
mean were identified as exhibiting additional motion. The
Figure 4. NMR-based analysis of mobility. Dynamics profiles mapped on the structures of PLAAT3 (A), PDB ID: 2KYT,8 and PLAAT4 (B), PDB
ID: 2MY9.7 Unassigned residues are shown in gray, residues showing neither fast nor slow time scale motions are shown in red, residues showing
only slow time scale dynamics are in pink, and residues showing only fast time scale dynamics are shown in green. Residues in fast or slow time
scale motions are labeled. The dynamic patch present in PLAAT4 that includes the catalytic triad residues H23 and H35 is labeled.
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residues demonstrating fast time scale (ps/ns) dynamics are
mapped on the structures of both proteins (Figure 4). Also,
residues for which resonances are not found in the spectra are
indicated, as these are likely to be involved in motions or
exchange processes. The Lipari−Szabo model-free ap-
proach50,66 was used to derive the order parameters (S2) of
the backbone amides from the 15N relaxation data. These are
reported in the Supporting Information, Tables S7 and S8 and
Figure S2.
To probe backbone motions in the slow (millisecond) time
scale, we acquired 15N-CPMG relaxation dispersion experi-
ments49 for both proteins at 14 and 20 T. Five residues of
PLAAT3 showed weak relaxation dispersion (Figure S3).
Three residues (V50, M51 and D56) are in the highly
disordered loop L1, one residue (D81) in the loop joining B5
and A2 and another residue (W24) is in B2 (Figures 4 and
S3). In contrast, 12 residues of PLAAT4 showed evidence for
millisecond dynamics (Figures 4 and S4). PLAAT4 has a
dynamic region consisting of 6 residues, R18, L19, Y21, K61
and the catalytic triad members H23 and H35. No resonance
could be assigned to C113, the catalytic cysteine. The
relaxation data of this region were fitted globally to a two-
site exchange model, yielding a population (pB) of 1% for the
minor state and an exchange rate (kex) of 1.9 (0.2) × 10
3s−1.
Dynamic parameters of residues in both PLAAT3 and
PLAAT4 are listed in Table S9.
To complement our insights from NMR studies and to
obtain dynamics information on PLAAT3 and PLAAT4,
classical all-atom MD simulations were performed using
NMR structures solvated in a cubic water box, neutralized by
counterions, and using the AMBERff99sb-ILDN force-field.59
Two runs of 100 ns were performed with different starting
velocities for both PLAAT3 and PLAAT4. The root-mean-
square deviation (RMSD) of the structural snapshots as
compared to the starting structure was taken as an indicator of
the global conformational stability of a structure during the
simulation (Figure 5A). In the first 10 ns, the RMSD steadily
increases as the protein samples different conformations. The
large RMSD observed for PLAAT4, as compared to that of
PLAAT3, indicates that considerable structural fluctuations are
taking place over the course of the simulations. The radius of
gyration fluctuated around a value that remained stable during
the MD simulations, with average values of 1.45 and 1.54 nm
for PLAAT3 and PLAAT4, respectively (Figure S6).
RMS fluctuations were calculated for all residues globally
(Figure S5) and also for the top two eigenvectors of the
principal component to study essential dynamics (concerted
motions). Residues with the highest RMS fluctuations of any
atom above 2 Å (Figure 5, panels B and C) were plotted on the
structures (Figure 5, panels D and E).
The regions showing major concerted fluctuations are
similar for PLAAT3 and PLAAT4, and are localized in the
termini, the major loop L1 and smaller loops. The main
difference is observed for loop L2(B6). In PLAAT4, this loop
shows concerted motions that are not observed in PLAAT3.
The amide NMR resonances in this PLAAT4 loop are partly
broadened beyond detection and partly involved in fast or slow
dynamics (Figure 4), evidence that indeed this loop is
dynamic. It is next to the area that was assigned as the
dynamic patch on the basis of millisecond dynamics (Figure
4B). In PLAAT3, the distances between the active site atoms
C113Sγ and H23Nδ and between H23Nε and H35Nδ all
remained below 5 Å (Figure S7), indicating that the active site
triad remained intact over the course of the MD runs. In
Figure 5. Molecular dynamics simulations of PLAAT3 and PLAAT4. (A) Plot of all-atom RMSD. Each point represents a snapshot saved at every
picosecond. PLAAT4 shows a higher RMSD, suggesting significant conformational fluctuations and rearrangements with respect to the starting
structure. (B, C) Fluctuations per residue. For each residue, the largest RMS fluctuation of all its atoms along the two largest eigenvectors (denoted
as Seed1_eigrmsf1 and Seed2_eigrmsf2) of the principal component analysis in the MD runs is plotted for PLAAT3 (B) and PLAAT4 (C). A
cutoff of 2 Å is indicated with a dashed line. Secondary structure of the starting structure is indicated at the top and named as in Table S2. (D, E)
Results of principal component analysis of the MD simulations. Residues colored in red in PLAAT3 (D) and PLAAT4 (E) show RMS fluctuations
above the cutoff of 2 Å. Apart from the C terminus, two distinct regions in PLAAT3 (19−22 and 43−55) were observed having concerted motions,
bringing them closer, while rest of the protein stays relatively rigid. PLAAT4 has three distinct mobile regions apart from the N and the C termini.
Loop L1 shows disordered movement, whereas regions 108−111 and 82−86 and residue 113 all show correlated motions.
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PLAAT4, C113Sγ exhibited an RMS fluctuation of 2.3 Å, while
its backbone atoms were more rigid (Figure 5C). The
rearrangement of loop L2(B6) caused disruption of the
interaction between the C113Sγ and the histidine rings of
the catalytic triad because the α-helix A3, of which C113 is a
part, is connected to this loop (Figure 5C). We conclude that
the L2(B6) motions, being interlinked with the interactions in
the active site, could influence the activity of the enzyme.
Loop Exchange Strongly Enhances PLAAT3 Activity.
To probe whether the mobility of L2(B6) affects the activity,
the L2(B6) loops of PLAAT3 and PLAAT4 (residues 103−
111) were exchanged (Figure 6). The mutants were named
PLAAT3_L2(B6)4 and PLAAT4_L2(B6)3.
To test whether the hybrid enzymes were catalytically active
and to establish the turnover rates, a phospholipase assay was
performed with the fluorescent substrate Red/Green BODIPY
PC-A2 (Figure 6C). The reaction rate of wild-type PLAAT4
was high, whereas wild-type PLAAT3 had background activity,
in line with earlier studies.2 Interestingly, PLAAT3_L2(B6)4
shows a large increase in the reaction rate. This observation
suggests that either the natural L2(B6)3 in PLAAT3 was
inhibiting the activity or that L2(B6) of PLAAT4 enables
activity. For PLAAT4_L2(B6)3, a small increase in activity was
seen, as compared to wild-type PLAAT4. Thus, replacement of
L2(B6)3 with L2(B6)4 in PLAAT3 enables activity, whereas
the opposite mutation does not inhibit activity in PLAAT4.
L2(B6)4 Disrupts Salt Bridges in PLAAT3. MD
calculations on the loop-swapped mutants did not yield clear
differences in dynamics between the wild-type proteins and the
mutants when analyzing the RMSD (Figure S8) or concerted
motions (Figures S9 and S10). As another measure of
structural integrity, the presence of salt bridges during the
MD run was analyzed. The presence of salt bridges was
sampled every 10 ps over the entire MD trajectory and
considered significant if the interaction was present on average
over 2 runs for at least 20% of the time. Surprisingly large
differences were found between wild-type and loop mutants. In
wild-type PLAAT3, 11 salt bridges were identified (Table S10,
Figure 7), whereas in PLAAT3_L2(B6)4, only five of these
remained. The lost interactions involved residues in the
L2(B6) loop but also across the active site and even at the
other end of the protein. Residues that lose the salt bridges
found in the wild-type protein form new ones with other
charged residues (Table S10, salt bridge pairs 12−15). A
similar picture arises from the data of PLAAT4. Out of seven
salt bridges in wild-type PLAAT4, only three were found in
PLAAT4_L2(B6)3 (Table S11, Figure 7). The lost bridges are
in the L2(B6) loop, the active site, and around D81, at the
other end of the protein. Only one new salt bridge was found
in PLAAT4_L2(B6)3. It is concluded that, despite the lack of
changes in the overall and loop RMSD, the average structures
clearly differ in details between wild-type and loop mutants.
Figure 6. Models of mutants of PLAAT3-L2(B6)4 (A) and PLAAT4-L2(B6)3 (B). The mutated regions are shown in contrasting colors. (C)
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■ DISCUSSION
We aimed to study the reason for activity differences between
the homologous enzymes PLAAT3 and PLAAT4. We
hypothesized that differences in dynamics could play a role
on the basis of observations accumulating over the years on the
role of C-terminal (CTD) and N-terminal domains of these
proteins. The transmembrane CTD was found to be crucial for
PLAAT3 PLA1/2 activity. Uyama et al.
45 showed that removal
of this domain resulted in loss of phospholipase activity. In
contrast, Golczak et al.2 demonstrated that PLAAT4 truncated
to its NTD has phospholipase activity, indicating that the
transmembrane C-terminal domain is not critical. Golczak et
al. also demonstrated that the rate of hydrolysis of short chain
phosphatidylcholines of NTD of PLAAT4 is faster than the
NTD of PLAAT3. Xia et al.7 reported that C-terminal domains
(CTDs) of both PLAAT4 and PLAAT3 can induce HeLa cell
death at a comparable level, while their NTDs play opposite
roles in regulating the cell death activity, even though their
structures are highly similar. The NTD of PLAAT4 was found
to be enhancing the cell death effect of the CTD, whereas the
NTD of PLAAT3 was found to be inhibitory. These authors
also complemented the observations of a previous study by
Scharadin et al.67 who found that residues 102−125, part of
the loop we renamed as L2(B6), of full-length PLAAT4 was
necessary for pericentrosomal localization. Based on NMR
studies, Wei et al.7 hypothesized that the motif (residues 102−
125) in PLAAT3 might be covered by the CTD while it was
exposed in PLAAT4. Therefore, we hypothesized that there
must lie a connection between the activities and overall
dynamics contributed by amino acid differences between
PLAAT3 and PLAAT4 NTDs and especially loop L2(B6).
The melting temperature of PLAAT3 is 15 °C higher than
that of PLAAT4, and the rotational correlation time is 33%
shorter, showing that in solution PLAAT3 is a more stable and
compact protein than PLAAT4. A comparison of the salt
bridge networks show that the former has a more extensive
network of salt bridges, which could explain these observations.
Both proteins feature a large loop (L1) that is known to be
disordered2,7,8,68 and is shown here to be mobile on the pico-/
Figure 7. Salt bridges in wild-type and loop mutant PLAAT proteins. Residues involved in salt bridges with an average occupancy of at least 20% in
the two 100 ns MD runs are shown with green spheres for Cα atoms. Dashed lines indicate the presence of salt bridges between the side chains of
the connected residues in wild-type only (red), wild-type and mutant (gray), or mutant only (yellow) for PLAAT3 (A), PLAAT3_L2(B6)4 (B),
PLAAT4 (C), and PLAAT4_L2(B6)3 (D). The residues of the catalytic triad are marked in yellow.
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nanosecond time scale. It has been proposed that L1 is a
membrane anchoring loop in the full length protein.68 It was
shown that replacement of L1 in PLAAT3 by the equivalent
loop of LRAT leads to induction of Vitamin A conversion.68
This indicates that the highly disordered loop may play a role
in modulating activity by interacting with the membrane.
Interesting differences are found between PLAAT3 and
PLAAT4 around the active site. PLAAT4 shows low order
parameters for R111 and N112, which immediately precede
the catalytic nucleophile C113. Because there are no NMR
resonance assignments for residues 106−110 and 113−114 in
PLAAT4, we assume that the peaks of these residues are
lacking because of line broadening due to motional chemical
exchange. Millisecond time scale dynamics experiments
identified a dynamic active site region involving residues 18,
19, 21, 23, 35, and 61. The resonance of G20 is missing, again
indicative of exchange broadening. Residue E22, which forms a
salt bridge with R111, shows no broadening due to chemical
exchange, which could imply that it either is not dynamic or its
change in chemical shift (Δω) happens to be small. Thus, the
active site region of PLAAT4 is dynamic, involving at least
residues 18−23, 35, 61, and also 113−114. Such a dynamic
patch is not observed in PLAAT3. We speculated that the
difference in dynamics can explain the activity differences
observed PLAAT3 and PLAAT4. The NTD of PLAAT3 may
show little activity toward its substrate due to lack of active site
dynamics, whereas the dynamics of PLAAT4 may enable its
activity. To develop a model of what the dynamics in PLAAT4
may entail, molecular dynamics simulations were used.
Although they can only sample fast dynamics, they still
provided insight into the nature of motions, and such
calculations are known to correlate with NMR relaxation
studies.69−72 The RMSD profiles obtained from the MD
simulations indicated that PLAAT4 is inherently more
dynamic than PLAAT3, supporting the NMR results. Using
PCA, we also demonstrated that the loop L2(B6) in PLAAT4
shows concerted motions that are absent in PLAAT3.
Thus, these observations raised the question whether the
mobility of L2(B6) relates to the activity difference between
PLAAT3 and PLAAT4. Increased flexibility could play a role in
substrate accessibility or induced fit. Introduction of the
PLAAT4 L2(B6) loop indeed increased the activity of
PLAAT3 strongly, though the opposite change, introducing
L2(B6) from PLAAT3 into PLAAT4, did not reduce activity.
By studying the lifetimes of the salt bridges during MD
simulations of L2(B6)-swapped structures, we could observe
that the introduction of a non-native L2(B6) disrupts the
inherent network of salt bridges, the disruption being more
prominent in PLAAT3, reducing some of the structural rigidity
which might enhance activity of PLAAT_L2(B6)4, perhaps by
increasing substrate accessibility or greater active site flexibility.
Apart from L2(B6), studying the interaction between
L2(B6) and the highly flexible loop L1 in modulating catalytic
activity (especially for PLAAT3) is another facet to a greater
understanding of the workings of these enzymes because the
two loops are adjacent to each other in NTD structures.
However, in light of the models proposed by Golczak et al.2
and Pang et al.23 for full-length enzymes, the two loops are
expected to be far apart when interacting with the membrane.
Wei et al.7 show that deletion of L1 in PLAAT3 enhances cell
death inducing ability, not necessarily the phospholipase
activity, because cell death inducing ability is conferred by
the C-terminal domain. The authors mention that it is still not
clear whether phospholipase activity plays any role in cell
death. Therefore, the role of loop L1 in modulating
phospholipase activity of PLAAT3 is unclear. We tried to
address the question of interaction between loops L1 and
L2(B6) in the NTD. Studying the interaction using NMR
spectroscopy poses challenges because the NH resonances of
the residues constituting L1 are broadened beyond detection.
The MD simulations show no evidence for contacts. The Cα
distances between two pairs of residues in L2(B6) and L1
[Q102 and L105/K105 (PLAAT3/PLAAT4) in L2(B6) and
A45 and V50 in L1] were calculated over the MD trajectory
(Figure S11). The two loops, however flexible, do not interact
significantly with each other.
Based on our findings, it can be concluded that PLAAT3 and
PLAAT4 are dynamic proteins and the motions involve large
parts of the structure. These motions clearly play an important
role in modulating the activity, making it hard to explain
activity differences with a simple model. For complete
structural understanding of the activity difference of PLAAT
family members, it will be important to compare the dynamics
of the NTDs with those of the full-length proteins in a
seminative environment, such as a Nanodisc. Studying full-
length proteins in Nanodiscs would also help decipher the role
of the CTD and any possible interaction between the CTD
and L1 loop because L1 also interacts with the membrane and
therefore should assume more defined conformation than the
highly flexible loop that is observed for the NTD. It would be
interesting to see if the interaction of the CTD and L1 with the
membrane bring about any conformational change or change
in dynamics in the NTD of PLAAT3, thereby rendering it
more catalytically active than NTD itself.
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